⚠️ Disclaimer

Dihexa is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Dihexa is being researched for brain applications. Potentiates hepatocyte growth factor (HGF) and its receptor c-Met, driving synaptogenesis (new synapse formation). Preclinical data shows it is millions of times more potent than BDNF at stimulating s. Common dosages for this use range from 10-40 mg daily once daily.

Can Dihexa Help With Brain?

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is being researched for brain applications based on its mechanism as a Synaptogenic neuropeptide, HGF/c-Met pathway agonist.

Potentiates hepatocyte growth factor (HGF) and its receptor c-Met, driving synaptogenesis (new synapse formation). Preclinical data shows it is millions of times more potent than BDNF at stimulating synapse growth. Also reduces neuroinflammation via NF-κB pathway suppression and protects neurons against oxidative damage.

What Does the Research Show for Dihexa and Brain?

Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials — preclinical only.

The relevance to brain specifically comes from Dihexa's effects on enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density.

What Protocol Is Used for Brain?

For brain applications, the standard Dihexa protocol is 10-40 mg daily administered once daily via oral (research protocols) for 8-12 weeks.

Some researchers adjust dosing based on the specific brain application — see our Dihexa dosage guide for full protocol details.

Can Stacking Improve Brain Results?

Complements Cerebrolysin (neurotrophic factors) and Semax (BDNF) for multi-pathway neuroprotection.

What Side Effects Apply to Brain Use?

Significant concern about potential cancer risk through HGF/c-Met pathway activation, which is involved in tumor progression. Could theoretically promote maladaptive neural wiring or tumorigenesis. No human clinical safety data available.

Side effects are generally consistent regardless of the specific application. See our Dihexa side effects guide for details.

Calculate Your Dihexa Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Dihexa.

Open Calculator →

Bottom Line: Dihexa for Brain

Dihexa shows preliminary research potential for brain. Standard protocols (10-40 mg daily, once daily, 8-12 weeks) apply.

Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.

Complete Guide

Dihexa : The Potent Nootropic Peptide Explained

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research Dihexa, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Peptides

Particle → Browse Peptides

Limitless → Browse Peptides

Apollo → Browse Peptides

Frequently Asked Questions

What is Dihexa?

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a Synaptogenic neuropeptide, HGF/c-Met pathway agonist. Synthetic derivation of Angiotensin IV with enhanced blood-brain barrier penetration. It is researched for enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density.

What is the recommended Dihexa dosage?

Common dosages: 10-40 mg daily administered once daily via oral (research protocols). Cycle length: 8-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.

What are the side effects of Dihexa?

Significant concern about potential cancer risk through HGF/c-Met pathway activation, which is involved in tumor progression. Could theoretically promote maladaptive neural wiring or tumorigenesis. No human clinical safety data available.

Is Dihexa safe?

Dihexa has shown a preliminary safety profile in research. Not FDA-approved. Investigational compound. Research context only. All research should follow appropriate safety protocols.